A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make ...

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...

DNA origami sounds like science fiction, but for HIV vaccine researchers it is becoming a practical design tool. By folding strands of DNA into tiny three-dimensional scaffolds, scientists can arrange ...

Please provide your email address to receive an email when new articles are posted on . Fifteen years ago, an HIV vaccine trial conducted in Thailand and sponsored by the U.S. Army found something no ...

South Africa has begun the first human trials of a locally developed HIV vaccine to defeat a virus that still kills around ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

The BRILLIANT 011, a first-in-human clinical trial, was officially launched at the Desmond Tutu HIV Foundation (DTHF) ...

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...

A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast. Although a person initially becomes infected with one or a few HIV strains, the virus replicates and ...